Introduction
Vancomycin-intermediate Staphylococcus aureus (VISA) strains have been increasingly reported worldwide. Unfortunately, the infections caused by VISA often result in poor clinical outcomes in patients treated with glycopeptides. [1] [2] [3] Phenotypically, VISA isolates exhibit several common characteristics such as thickened cell walls, 4 reduced autolysis 5 and attenuated virulence allowing immune escape and long persistence. 6 However, the genetic mechanisms responsible for reduced vancomycin susceptibility in VISA vary. 7 Genomic comparisons of isogenic vancomycin-susceptible S. aureus (VSSA)/VISA pairs reveal that mutations in genes encoding two-component systems (TCSs) such as vraSR, 8 graSR 9,10 and walKR, 11, 12 and other genes such as the RNA polymerase b subunit (RpoB), 13 are responsible for the development of VISA. However, the molecular mechanisms underlying vancomycin resistance in VISA have been incompletely defined, and only a small number of mutations in several genes have been experimentally examined.
TCSs are important regulatory systems used by bacteria to sense and respond to a wide range of signals. The sensor kinase of a TCS is involved in the recognition of extracellular stimuli and the modulation of intracellular autokinase activity. The activated sensor kinase activates the response regulator by transferring its phosphoryl group to the latter, which then regulates the expression of various genes in response to the signals. 14 Of 16 TCSs 15 identified in S. aureus, WalKR(YycGF) is the only TCS essential for viability, and appears to link cell wall biosynthesis to cell division. 16 Mutations in WalKR have been found frequently in clinical VISA strains. 12 However, only three mutated forms of WalKR have been experimentally verified to be associated with vancomycin resistance. Shoji et al. 11 found that the WalK (DQ371) mutation in a laboratory-derived VISA strain influences vancomycin resistance, but it is not sufficient to confer the full vancomycin-intermediate phenotype. The WalK(G223D) mutation in the laboratory-derived VISA strain SV-1 confers a low level of vancomycin resistance, and V C The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
the mutated WalK protein exhibits decreased autophosphorylation, leading to reduced phosphorylation of the WalR response regulator. 17 An allelic replacement experiment demonstrated that WalK(G223D) and GraS(T136I) double mutation can convert VSSA to full vancomycin-intermediate resistance, whereas the introduction of WalR(K208R) is sufficient to convert VSSA to full intermediate resistance to vancomycin. 18 These studies demonstrate that different mutations have variable contributions to vancomycin resistance in VISA.
We previously characterized the first ST239 VISA strain XN108 (vancomycin MIC " 12 mg/L) that was isolated in the Chinese mainland.
19 XN108 has a circular 3 052 055 bp chromosome. 20 In the study reported here, comparative genomics analysis identified mutations in 33 genes, including a novel mutation WalK(S221P) that may play an important role in the reduced vancomycin susceptibility phenotype observed in XN108. The introduction of WalK(S221P) into the vancomycin-susceptible strain N315 increased its vancomycin resistance, while the allelic replacement of WalK(S221P) in XN108 with WalK(P221S) decreased its vancomycin resistance. The vancomycin resistance phenotypes of the strains were associated with thickened cell walls, decreased autolytic activities and gene expression profiles consistent with these changes. The mutant WalK(S221P) protein exhibited reduced autophosphorylation. When WalR was activated by WalK(S221P), it exhibited reduced affinity for the promoter region of lytM, a known WalR target. We conclude that the WalK(S221P) mutation plays a key role in mediating vancomycin resistance in XN108.
Materials and methods

Bacterial strains and growth conditions
Bacterial strains and plasmids used in the study are listed in Table S1 (available as Supplementary data at JAC Online). Unless otherwise indicated, S. aureus strains were grown in brain heart infusion (BHI) or MuellerHinton broth (Oxoid). Escherichia coli strains were grown in LB medium (Oxoid) at 37 C or 30 C when carrying temperature-sensitive plasmids. For plasmid maintenance, media were supplemented with ampicillin (100 mg/ L) or chloramphenicol (20 mg/L) as needed.
Genome comparison of XN108 and TW20
The whole genome sequencing of XN108 was carried out using the Ion Torrent PGM sequencer. 20 Phylogenetic analysis of the XN108 genome (GenBank accession no. CP007447) against the complete bacterial genome collection in GenBank revealed that XN108 is closely related to TW20 (NC_017331), a vancomycin-susceptible ST239 MRSA strain isolated in England. 21 Comparison of the XN108 and TW20 genome sequences was performed using Mummer (http://mummer.sourceforge.net/). Variations in XN108 were confirmed by Sanger sequencing. The novel mutation WalK(S221P) in XN108 was selected for further investigation as a potential contributor to vancomycin resistance.
Allelic replacement experiments to construct N315-WalK(S221P) and XN108-WalK(P221S) Because XN108 is a clinical isolate, the WalK(S221P) allele of XN108 was first introduced into the vancomycin-susceptible S. aureus strain N315 to generate the allelic replacement strain N315-WalK(S221P). Briefly, the gene encoding WalK(S221P) was amplified by PCR from XN108 genomic DNA using primer pairs, pBT2-walK-5 0 and pBT2-walK-3 0 (Table S2) , and cloned into the temperature-sensitive shuttle vector pBT2 22 that is widely used for markerless double homologous recombination. The pBT2-WalK(S221P) plasmid was transformed into S. aureus strain RN4220, extracted, purified and then electro-transformed into N315 to generate N315-WalK(S221P) after recombination had occurred. The presence of the WalK(S221P) mutation after allelic exchange was confirmed by Sanger sequencing. The reverse mutant XN108-WalK(P221S) was constructed using similar allelic replacement techniques.
Antibiotic susceptibility determination
Antibiotic susceptibility was determined by Etest with a vancomycin strip according to instructions provided by the manufacturer (AB Biodisk, Sweden). The population analysis was conducted as described previously. 23 All determinations were performed using BHI broth or agar.
Triton X-100-stimulated autolysis
Triton X-100-stimulated autolysis was performed as previously described with modifications. 24 Briefly, the strains were grown in Trypticase soy broth (TSB) to early exponential phase (OD 600 " 1.0) at 37 C with shaking. Bacterial cells were collected by centrifugation, washed twice with 0.05 M Tris-HCl buffer (pH 7.5), resuspended in an equal volume of Tris-HCl buffer containing 0.05% (v/v) Triton X-100, and incubated at 37 C with shaking. The decrease in the optical density at 600 nm (OD 600 ) was measured each hour using a microplate reader (SpectraMax V R M2/M2e, USA). The experiment was repeated at least three times with similar results.
Transmission electron microscopy (TEM)
Strains were cultured in TSB for 24 h at 37 C with shaking. Samples were prepared as previously described and observed under a TECNAI 10 transmission electron microscope (Philips, The Netherlands). 25 Cell wall thickness was determined in four separate quadrants of each cell, and over 30 cells with nearly equatorial cut surfaces were chosen from each strain for determination. The results are expressed as means + SD and the data were evaluated using Student's t-test, where P , 0.05 was considered statistically significant. All statistical tests were two-tailed.
Quantitative real-time RT-PCR (qRT-PCR)
Total bacterial RNA was extracted as previously described. 25 Briefly, overnight cultures of S. aureus were diluted 1:100 in TSB, grown to exponential phase and then harvested. Bacteria were lysed using lysostaphin (Sigma Life Science, USA) prior to RNA extraction. Total RNA (500 ng) was treated with DNase (TaKaRa, China) at 37 C for 30 min followed by the addition of 10% (v/v) stop solution. The resulting mixture was then incubated at 65 C for 10 min to eliminate possible DNA contamination. Then, cDNA was synthesized using a PrimeScript RT reagent kit (TaKaRa) from 500 ng of RNA with random primers in a 10 lL reaction mixture. The qRT-PCR was performed with SYBR Premix ExTaq (TaKaRa) using the Bio-Rad CFX96 TM Realtime detection system (Bio-Rad, USA). The primers used are listed in Table S2 . The housekeeping gene gyrB was used as an internal control. The expression level of gene of interest was normalized against gyrB gene expression, then the average ratio for a certain gene expression in XN108 was set to 1. The assays were repeated with three independent biological samples. Statistical analyses were performed based on the Student's t-test to determine the significance of the gene expression levels, where P , 0.05 was considered statistically significant.
Preparation of recombinant WalK, WalK(S221P) and WalR proteins
Using the primers listed in Table S2 , the genes encoding WalK(S221P) and WalR were amplified from XN108 genomic DNA, and the gene encoding WalK(P221S) was amplified from N315 genomic DNA. After digestion and WalK mutation confers vancomycin resistance in VISA JAC purification, target fragments were cloned into the expression vector pET22b (Novagen, Germany), then transformed into E. coli BL21 (DE3) competent cells. The recombinant bacterial cells were grown in LB at 37 C to an OD 600 of 0.5 and induced with 1 mM IPTG at 25 C for 16 h. The cells were harvested and lysed by sonication in a lysis buffer (50 mM Tris-HCl, 200 mM NaCl, pH 8.0). The proteins were purified from the supernatant using columns containing Ni 2! -nitrilotriacetate-agarose resin, guided by protocols provided by GE Healthcare Life Sciences. Protein purity was determined by SDS-PAGE, and protein concentration was determined using a BCA assay with BSA as a control. Preparations of recombinant proteins were supplemented with 30% glycerol and stored at #80 C until use.
Autophosphorylation assay
As a sensor kinase, WalK has an autophosphorylation activity that can be detected in vitro. 17 Briefly, 10 lL phosphorylation buffer (50 mM Tris-HCl, 50 mM KCl, 5 mM MgCl 2 , pH 7.4), containing 2 lM recombinant WalK(P221S) or WalK(S221P) and 0.5 lCi [k-32 P]ATP was incubated for 1 or 10 min at room temperature to initiate autophosphorylation. The reaction was stopped by the addition of 5% SDS loading buffer. Autophosphorylated proteins were analysed by protein electrophoresis and autoradiography of stained, dried gels.
Electrophoretic mobility shift assay (EMSA)
The EMSA has been used extensively for exploring DNA-protein interactions. Biotin-labelled DNA fragments containing the putative promoter region of lytM (253 bp) were obtained by PCR using the primers listed in Table S2 . For EMSA, various amounts (0, 0.5, 1 and 2 lM) of WalR were incubated with 2 lM WalK(P221S) or WalK(S221P) and 20 fmol of biotin-labelled lytM promoter region DNA in 1% binding buffer (LightShift Chemiluminescent EMSA Kit; Thermo Scientific) containing 50 mg/mL poly(dI-dC), 0.05% Nonidet P-40, 5 mM MgCl 2 , 10 mM EDTA and 2.5% glycerol. The reactions were initiated by the addition of 20 lM ATP at room temperature for 20 min. Mixtures were loaded onto native 8% polyacrylamide gels preelectrophoresed for 60 min in 0.5% Tris-borate-EDTA (TBE) buffer and electrophoresed at 100 V before being transferred on to a positively charged nylon membrane in 0.5% TBE buffer for 30 min. The transferred DNAs were cross-linked to the membrane using ultraviolet light at 120 mJ/cm 2 and detected using horseradish peroxidase-conjugated streptavidin (LightShift TM chemiluminescent EMSA kit) according to the manufacturer's instructions.
Results
Genome of XN108 contains mutations that may confer vancomycin resistance XN108 was the first VISA isolate (vancomycin MIC " 12 mg/L) of the MRSA ST239 identified in mainland China. 19 To identify genetic variations that might be associated with vancomycin resistance, we compared the XN108 genome 20 with that of TW20, 21 another ST239 MRSA isolated in England that is vancomycin susceptible. A total of 46 mutations in various putative genes were identified. Non-synonymous mutations occurred in 33 genes (Table S3) , including GraS(T136I), RpoB(H481N) and a new WalK variant WalK(S221P). All three mutations were verified by PCR amplification and re-sequencing. The GraS(T136I) mutation may confer a low level of vancomycin resistance in ST239 MRSA. The GraS(T136I) mutation in JKD6009 (ST239-MRSA) raises the Peng et al.
vancomycin MIC up to 4 mg/L, compared with the parental strain JKD6008 (vancomycin MIC " 2 mg/L). 12 The role of RpoB mutations in VISA vancomycin resistance has also attracted interest. 13 Matsuo et al. 26 demonstrated that RpoB(H481Y) converts heterogeneous VISA to a VISA phenotype in strain Mu3. However, most ST239-MRSA strains derived from Chinese hospitals carry RpoB H481N ! L466S double mutations that confer resistance to rifampicin but not vancomycin. 27, 28 Since WalK(S221P) appears to be a novel mutation in VISA strain XN108, we focused our efforts on its possible role in vancomycin resistance.
WalK(S221P) contributes to vancomycin resistance in S. aureus
Because genetic manipulation is challenging in clinical strains of S. aureus, we first performed an allelic replacement experiment by substituting walK in the vancomycin-susceptible strain N315 with walK from XN108. The reconstituted N315-WalK(S221P) has an increased vancomycin resistance (MIC " 8 mg/L) compared with that of the parental strain N315 (MIC " 1.5 mg/L) (Figure 1a  and 1b) . This result suggests that the WalK(S221P) mutation in XN108 plays an important role in VISA. We then performed the Triton X-100-stimulated autolysis assay. Bacterial cells were grown in BHI broth and the autolytic activity was determined with each strain as described in Materials and methods. Test was repeated three times, and one representative experiment is shown.
(c) Expression of isaA, lytM, atlA and ssaA genes associated with autolytic activities, (d) the dltA, mprF, murG and glmU genes associated with cell wall synthesis and modification, and (e) the genes associated with virulence of XN108 and XN108-WalK(P221S) determined by qRT-PCR. Quantitatively analysed data are presented as means + SD (n " 3). **P , 0.01; *P , 0.05; NS indicates no significance.
WalK mutation confers vancomycin resistance in VISA JAC reciprocal experiment, and replaced walK in XN108 with walK from N315. The reverse mutant strain XN108-WalK(P221S) exhibited a decrease in vancomycin MIC from 12 mg/L (XN108 parental strain) to 4 mg/L (Figure 1c and 1d) . Experiments in which antibiotic susceptibility was measured in cell populations using a range of vancomycin concentrations confirmed that the WalK(S221P) mutation is responsible for the reduced vancomycin susceptibility in VISA (Figure 2a ) and plays a key role in the development of vancomycin resistance in XN108.
WalK(S221P) contributes to commonly observed VISA characteristics
Although the underlying genetic mechanisms vary, VISA strains often exhibit common features such as thickened cell walls and decreased autolysis. To determine whether WalK(S221P) also confers these phenotypes, we examined the morphologies of strains N315 and XN108 as well as their derivatives N315-WalK(S221P) and XN108-WalK(P221S) using TEM. Compared with N315 and XN108-WalK(P221S), the cell walls of N315-WalK(S221P) and XN108 were significantly thickened ( Figure 3 ). Using Triton X-100-induced autolysis assays, both N315-WalK(S221P) and XN108 showed reduced autolytic activity compared with their counterparts (Figure 2b ).
WalK(S221P) alters the expression of genes involved in cell wall metabolism and virulence regulation
WalKR, identified as the only essential TCS in S. aureus, is associated with cell wall metabolism. Genes involved in cell wall autolysis such as atlA, ssaA, isaA and lytM are positively controlled by the WalKR system. 29, 30 To test whether the WalK(S221P) mutation affects the expression of autolysis genes, we determined the relative transcript levels of these genes in XN108 and the reverse mutant XN108-WalK(P221S) by qRT-PCR. As shown in Figure 2c , the expression of atlA, ssaA, isaA and lytM were significantly decreased in XN108 compared with the allele-replacement strain XN108-WalK(P221S). This result is consistent with the results in the Triton X-100-induced autolysis assay (Figure 2b ). In contrast, we found that the expression of genes involved in cell wall biosynthesis of XN108, such as glmU and MurG, increased significantly. In addition, genes encoding enzymes for D-alanylation of the wall teichoic acids, such as dltA, and for L-lysylination of phosphatidylglycerol, such as mprF, were expressed at slightly higher levels in XN108 relative to levels in XN108-WalK(P221S) (Figure 2d ). Together, these results suggest that the novel WalK(S221P) mutation in XN108 plays a key role in the promotion of vancomycin resistance by decreasing the expression of autolysis genes (resulting in reduced autolysis activity) and increasing the expression of genes involved in cell wall biosynthesis (resulting in cell wall thickening).
VISA is characterized by not only gene expression changes in the cell wall metabolism but also altered expression of global virulence regulators. 7 Given the frequent therapeutic failure of VISA infections, VISA isolates demonstrated decreased virulence. [31] [32] [33] [34] Gardete et al. 18 revealed that the virulence-related genes such as agrA, sarH1, spa, etc., were down-regulated in the VISA strain SG-R when compared with their transcription in the parental strain SG-S. To test whether the WalK(S221P) mutation affects the expression of virulence regulation genes, we also determined the relative transcript levels of agrA, rot, sarH1, spa and lukD genes in XN108 and the reverse mutant XN108-WalK(P221S) by qRT-PCR. We found that all these genes were significantly down-regulated (agrA, sarH1, spa and lukD) or slightly decreased (rot) in XN108 compared with the allele-replacement strain XN108-WalK(P221S) (Figure 2e ).
WalK(S221P) exhibits decreased autophosphorylation, affecting WalKR activity
To examine the biochemical effects of the WalK(S221P) mutation on WalKR activity, recombinant WalK(P221S), Walk(S221P) and WalR proteins were expressed, purified and subjected to (Figure 4) . We then tested whether the decreased phosphorylation level of WalK(S221P) affects WalR-controlled gene expression by monitoring WalR binding at the promoter region of the autolysin gene lytM, a target of WalR. Fragments carrying the promoter region were amplified by PCR and used as substrates in a gel shift assay (EMSA). As shown in Figure 5 , the WalR that was phosphorylated by WalK(P221S) bound specifically to the lytM promoter in a concentrationdependent manner. In contrast, WalR that had been phosphorylated by WalK(S221P) exhibited a reduced capacity to bind to the lytM promoter. These results indicate that the WalK(S221P) mutation decreases autophosphorylation and reduces the ability of WalR to activate the transcription of its target genes.
Discussion
S. aureus is a versatile pathogen because of its ability to adapt to host defences during infection and to stress caused by antibiotics. 35 With the increasing use of vancomycin since the 1980s, S. aureus isolates with reduced vancomycin susceptibility have emerged, raising health concerns worldwide. 36 Although spontaneous mutations in several regulatory genes have been shown to contribute to vancomycin resistance in VISA, 12,37-41 only a few mutations have been investigated in detail. In this study, we used allelic exchange experiments to characterize a naturally occurring WalK(S221P) mutation, and determined that this mutation plays a key role in the vancomycin resistance of clinical VISA strain XN108. The introduction of WalK(S221P) into N315 was sufficient to convert this strain from VSSA to VISA. Conversely, the replacement of WalK(S221P) in XN108 with WalK(P221S) from N315 decreased the vancomycin MIC in the reconstituted strain from 12 to 4 mg/L. The fact that the reconstituted strain is still VISA suggests that other mutations, such as GraS(T136I) and RpoB(H481N), may contribute to vancomycin resistance in XN108. In future experiments, the sequential introduction of all potential mutations identified in XN108 to a VSSA strain to reconstitute the full VISA phenotype will help illuminate the mechanism underlying vancomycin resistance in XN108.
WalK is the sensor kinase component of WalKR, an essential S. aureus TCS that controls genes involved in cell wall metabolism, such as atlA, ssaA, isaA, sle1 and lytM. 30 Our results indicate that the lytM, ssaA, issA and atlA genes are expressed at a low level in the WalK(S221P) mutant, confirming studies by Hu et al. 17 We hypothesize that the decreased expression of autolysins in the walKR regulon contributes to the observed reduction in autolytic activity. Furthermore, we found that genes related to cell wall synthesis are expressed at higher levels in XN108. The increase in expression is likely to accelerate cell wall biosynthesis, leading to thickened cell walls. WalK has two transmembrane helices, a C-terminal kinase domain and an extracellular Per-Arnt-Sim domain, which may be involved in signal sensing. 42 More than 20 mutations have been identified in the WalK gene from clinical and laboratory-derived WalK mutation confers vancomycin resistance in VISA JAC VISA strains. The effects of two mutations, WalK(G223D) and WalK (DQ371), have been experimentally verified. 11, 17 In our study, the novel WalK(S221P) mutation in XN108 is found at a highly conserved residue within the HAMP (Histidine kinases, Adenylyl cyclases, Methyl binding proteins, and Phosphatases) domain, which connects the extracellular sensory and intracellular signalling domains. 16 The HAMP domain of WalK relays conformational changes to regulate signal transmission. This domain possesses a homodimeric, four-helical, parallel coiled coil with unusual interhelical packing, related to the canonical packing by rotation of the helices. 43 The WalK(S221P) mutation may sterically hinder the conformational change and cause the decrease in WalK autophosphorylation activity observed in this study (Figure 4) . The EMSA experiment showed that WalR can bind specifically to the lytM promoter, and WalK(S221P)-phosphorylated WalR exhibited a reduced capacity to bind to the promoter region.
The clinical VISA strain XN108 belongs to the ST239 clonal lineage, which was the most prevalent MRSA clone in mainland China. 44, 45 Such an isolate has an exceptionally high potential to cause disease, mainly due to acquired multiple drug resistance and attenuated virulence allowing immune escape and long persistence. The acquisition of VISA type resistance seems to be accompanied by attenuation of virulence expression. 18, 33, 39 In our study, qRT-PCR revealed that the virulence factor genes such as agrA, sarH1, spa and lukD were significantly down-regulated in the VISA strain XN108, consistent with the findings of other studies with different VISA isolates. 46, 47 This phenomenon indicates that decreased virulence in VISA may be associated with the same mutated gene that is also responsible for the decreased vancomycin susceptibility. It has been proposed that the downregulation of virulence may represent a 'stealth' strategy of the bacteria to evade surveillance by the host immune system. 18 In conclusion, this study highlights the potential for a single nucleotide change in S. aureus to dramatically affect bacterial antimicrobial resistance. Our data indicate that a naturally occurring WalK(S221P) mutation is sufficient to confer vancomycin resistance in VISA. The most likely mechanism is that the WalK (S221P) mutation reduces the autophosphorylation of WalK, thereby decreasing the ability of WalK to activate the response regulator WalR. In turn, this decreases the expression of genes for autolytic activities and virulence, and increases the expression of genes for cell wall synthesis. Both effects on gene expression contribute to the reduced vancomycin susceptibility in VISA.
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